Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project Amid Critical Mineral Push NATO Defense Spending to Reach Hundreds of Billions Rutte Says as Trump Pledges 5000 Additional Troops to Poland Q4 Results 2026 RVNL Suzlon ONGC IRCTC GMR Airports and IndiGo Among Companies Reporting Next Week Meta Could Enter Cloud Computing Business as Data Center Overcapacity Looms Zuckerberg Says New EV Brand Backed by Five Companies Targets Japans Mini Car Market Top10 Valued Firms See Combined Market Cap Rise by 74111 Crore Reliance Leads Gains Bogota Financial Corp BSBK Q1 2025 Earnings EPS of 006 Reported Shares Dip 118 United Community Banks Inc UCB Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower EVGO Q1 2026 Earnings Narrower Loss Surpasses Analyst Expectations Amidst Operational Gains GAIA Q1 2026 Earnings Slight EPS Miss Stock Rises as Investors Focus on Strategic Initiatives CLNN Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Ongoing Clinical Progress Exodus Movement Inc EXOD Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Data Unavailable Molina Healthcare Shows Modest Gains as Sector Tailwinds Support MOH FGBIP Preferred Stock Holds Steady at 2049 as Yield Attracts Income Seekers Prudential Financial Junior Subordinated Notes PRS Nears Support as Yields Attract Consideration Leonardo DRS DRS Rides Defense Momentum Testing Key Resistance at 48 AtlasClear Holdings ATCH Hovers Near Support Amid Mild Selling Cramer Comments on Atlassians YouTube Controversy Amid Steep Stock Decline Jim Cramers Latest Claim on CrowdStrike Sparks Market Speculation Inherited 401k Rules Failing to Follow Withdrawal Guidelines Could Trigger a 25 IRS Penalty Reddit Reports 69 Revenue Surge Topping Analyst Estimates Overlooked Dividend King Industrial Sectors Hidden Gem May Offer LongTerm Value General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range Brilliant Earth Group Inc BRLT Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Operational Progress Acrivon Therapeutics ACRV Narrows Lower as Biotech Sentiment Remains Cautious